Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus

Obesity Surgery

Volumn 22, Issue 8, 2012, Pages 1238-1243

  Lee, Woohyung ^a,b   Ahn, Sang Hoon ^a,b   Lee, Jue Hee ^a,b   Park, Do Joong ^a,b   Lee, Hyuk Joon ^a   Kim, Hyung Ho ^a,b   Yang, Han Kwang ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Diabetes mellitus resolution; Gastric cancer; Reconstruction type

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESOPHAGOJEJUNOSTOMY; FEMALE; GASTRECTOMY; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; GASTROJEJUNOSTOMY; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; ROUX Y ANASTOMOSIS; STOMACH CANCER;

AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RECONSTRUCTIVE SURGICAL PROCEDURES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84864883662     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0580-1     Document Type: Article

References (20)

1. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA. 2004;292:1724-37.
2. Thomas S, Schauer P. Bariatric surgery and the gut hormone response. Nutr Clin Pract. 2010;25:175-82.
3. Zervos EE, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg. 2010;210:564-72.
4. John B, Sonia C, William T, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133-35.
5. Thaler JP, Cummings DE. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518-25.
6. Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol(Oxf). 2008;69:173-9.
7. Jeon TY, Lee S, Kim HH, et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab. 2004;89:5392-6.
8. Tong J, Prigeon RL, Davis HW, et al. Ghrelin suppresses glucosestimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes. 2010;59:2145-51.
9. Cummings DE, Overduin J, Foster-Schubert KE, et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007;3:109-15.
10. Meirelles K, Ahmed T, Culnan DM, et al. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg. 2009;249:277-85.
11. Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptidesecretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3:597-601.
12. Brubaker PL, Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol. 2003;81:1005-12.
13. Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology. 1999;140:1687-94.
14. Yang J, Li C, Liu H, et al. Effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of type 2 diabetes mellitus. J Surg Res. 2010;164:e67-71.
15. Lanzarini E, Csendes A, Lembach H, et al. Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: Retrospective study. World J Surg. 2010;34:2098-102.
16. Yamamoto H, Tsuchihashi H, Akabori H, et al. Postprandial hyperglycemia after a gastrectomy and the prediabetic state: A comparison between a distal and total gastrectomy. Surg Today. 2008;38:685-90.
17. Damjanovic SS, Lalic NM, Pesko PM, et al. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastectomized patients. J Clin Endocrinol Metab. 2006;91:2574-81.
18. Takachi K, Doki Y, Ishikawa O, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 2006;130:1-7.
19. Wiedman P, Nogueiras R, Broglio F. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab. 2007;3:705-12.
20. Miholic J, Orskov C, Holst JJ, et al. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dis Dig Sci. 1991;36:1361-70.